Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd10-03-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ECL Finance LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdUpdates on Subsidiary
With reference to the earlier letter dated August 03, 2016, Fortis Healthcare Ltd has now informed BSE that Fortis Hospitals Limited, subsidiary of the Company on February 15, 2017 has informed the Company that it has increased its shareholding in Fortis Health Management (East) Limited (FHMEL) by 6,000 equity shares (i.e. 12% of total paid-up share capital of FHMEL ) of Rs. 10 each.Investor Presentation
Fortis Healthcare Ltd has informed BSE regarding "Investor Presentation" - Q3 & 9MFY 17.Fortis posts 453-crore profit on demerger move
The company's strategy to demerge its diagnostic business, and consolidate the hospital business is a significant contributor to this massive gain.Revised Financial Results for the Quarter ended December 31, 2016
With reference to the earlier letter dated February 14, 2017 regarding Financial Result for the December 31, 2016, Fortis Healthcare Ltd has now informed BSE that there was an inadvertent typographical error under "Statement of unaudited Standalone and Consolidated Financial Results" Point no. 18 i.e. Paid-up equity share capital and Point no. 19 i.e. Earnings per share.The revised financial result for the quarter and period ended December 31, 2016 is enclosed.